California Stem Cell Agency Chair Sells Interest in Advanced Cell Technology
Jonathan Thomas, at right, at his first CIRM board meeting in June. Outgoing
Chairman Robert Klein is at left and co-Vice Chairman Art Torres in center.
The new chairman of the $3 billion California stem cell agency, Jonathan Thomas, has sold "at a significant loss" the 17,046 shares he held in a California-based stem cell firm.
In response to a query fr…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.